Skip to main content
logo
GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
48.74
-2.20 (-4.32%)
At close: Oct 28, 2026, 4:00 PM EDT
48.81
+0.07 (0.14%)
After-hours: Oct 28, 2026, 7:54 PM EDT

GSK Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
-8,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,1477,1786,9517,3767,8296,9297,1907,076
Revenue Growth
-5.30%1.50%6.17%6.68%1.29%2.08%0.81%-1.66%9.84%5.93%9.16%4.06%3.59%-3.32%4.24%18.14%18.69%39.48%-19.03%
Gross Profit
-6,3375,7566,0016,3085,8215,5905,5805,6845,8225,4455,7155,9045,2795,0484,6895,6154,7844,5004,315
Operating Income
-2,6022,7681,6313,0822,3922,3101,0036672,1492,3051,7212,7652,0021,9238952,5421,7091,8191,062
Net Income
-4351,7376362,0131,4431,624414-581,1731,0463501,4641,6241,4901,49510,8218381,802749
Earnings Per Share
0.380.110.430.160.490.350.390.10-0.010.280.250.090.360.400.360.372.650.210.440.18
EPS Growth
-22.81%-69.52%8.40%54.72%-23.16%54.72%17.32%--28.21%-30.41%-76.55%-86.55%92.27%-17.84%98.82%819.92%-40.29%67.08%9.19%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
HIV
2,1162,0781,8242,1491,9441,8801,7141,9691,7501,7571,6131,7731,6231,5801,4681,6781,4861,4041,1811,260
Respiratory, Immunology and Inflammation
1,1391,1358901,089954963804910843911635863769792601721688680520-
Oncology
622569512567511484415408373356273244200151136157164154127132
Shingles
7808881,0261,008830853867848739832945908825880833769760731698597
Meningitis
599462335313541379350295520323299273441266280228441235212194
RSV
19519265198251667815818862182529709-------
Influenza
177111080216611052837139537423122763883218244
Other Paediatric & Adult Vaccines
832731713694840787799806920775838771868812815743884717741682
Respiratory
1,7081,6791,5941,7851,7021,8711,7101,8061,6172,0651,7251,7461,5201,7921,7671,6821,6821,6491,535-
Other General Medicines
719664660735758697778801779796839830817841907939919861808-
Revenue (Total)
8,8878,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,1477,1786,9517,3767,8296,9297,1907,076

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
2,9623,1063,4433,4213,3063,6194,4853,9663,2122,9834,0955,2806,6836,5046,9758,0427,1616,53213,9774,965
Total Debt
23,80218,29319,11217,78717,75017,35418,43216,98616,05916,94317,77218,01820,83621,47420,90520,98722,11522,11233,35124,174
Net Cash (Debt)
-20,840-15,187-15,669-14,366-14,444-13,735-13,947-13,020-12,847-13,960-13,677-12,738-14,153-14,970-13,930-12,945-14,954-15,580-19,374-19,209
Net Cash Growth
--------------------
Net Cash Per Share
-5.12-3.74-3.85-3.52-3.52-3.34-3.37-3.14-3.10-3.39-3.33-3.09-3.44-3.66-3.41-3.16-3.66-3.83-4.76-4.73

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
2,8092,6901,1412,2782,2222,0961,1452,3292,1541,1139583,1962,2121,307531,9051,3211,6352,5423,767
Capital Expenditures
-374-328-221-573-311-256-208-544-305-302-248-486-299-296-233-438-275-237-193-374
Free Cash Flow
2,4352,3629201,7051,9111,8409371,7851,8498117102,7101,9131,011-1801,4671,0461,3982,3493,393
Free Cash Flow Growth
27.42%28.37%-1.81%-4.48%3.35%126.88%31.97%-34.13%-3.35%-19.78%-84.73%82.89%-27.68%--56.76%-55.26%-1706.92%1.56%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
74.91%75.36%75.45%69.63%73.80%72.89%74.38%68.75%70.94%73.85%73.95%70.98%72.47%73.54%72.62%63.57%71.72%69.04%62.59%60.98%
Operating Margin
-30.94%36.28%18.93%36.06%29.95%30.73%12.36%8.33%27.26%31.30%21.37%33.94%27.89%27.66%12.13%32.47%24.66%25.30%15.01%
Pretax Margin
-4.21%28.10%11.02%28.74%23.63%28.05%6.94%0.80%18.96%18.40%4.71%21.98%27.68%27.43%22.04%12.93%12.93%29.12%4.28%
Profit Margin
-5.17%22.77%7.38%23.55%18.07%21.61%5.10%-0.72%14.88%14.21%4.35%17.97%22.63%21.44%20.27%138.22%12.09%25.06%10.59%
FCF Margin
-28.09%12.06%19.78%22.36%23.04%12.47%21.99%23.08%10.29%9.64%33.66%23.48%14.09%-2.59%19.89%13.36%20.18%32.67%47.95%

Dividends
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Dividend Per Share
0.1700.1700.1700.1800.1600.1600.1600.1600.1500.1500.1500.1600.1400.1400.1400.1380.1380.1630.1750.287
Dividend Per Share Growth
6.25%6.25%6.25%12.50%6.67%6.67%6.67%0%7.14%7.14%7.14%16.36%1.82%-13.85%-20.00%-52.17%-42.10%-31.58%-26.32%0%
Dividend Yield
3.77%3.45%3.26%3.62%4.07%4.53%4.26%4.53%4.02%3.92%3.45%3.98%3.74%4.00%4.06%4.23%5.82%3.89%4.53%4.98%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
-16.3614.1612.8111.5416.4318.8521.34-15.4715.5712.009.963.653.943.903.7219.6116.3018.35
P/FCF Ratio
9.8911.4412.9411.459.798.7711.0410.6610.1710.1511.0110.8414.3616.83-9.336.469.4310.3213.73
PS Ratio
-2.382.522.241.971.781.891.751.981.982.271.952.041.921.981.991.823.213.123.26